Marshall Fordyce, PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 31,250 shares at $38.83 ($1.2M) on 2024-10-09, disclosed to the SEC on 2024-10-11.
Scheduled sale ($1.2M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.08 | 12,273 | $467K | 39.1% |
| 2 | $38.08 | 12,273 | $467K | 39.1% |
| 3 | $38.83 | 3,352 | $130K | 10.9% |
| 4 | $38.83 | 3,352 | $130K | 10.9% |
| Total | $38.24 avg | 31,250 | $1.2M | 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |